Skip to main content

Medicenna Therapeutics: Top 10 Undervalued Biotechnology Industry Stocks (MDNA)

AI-generated - The Globe and Mail - Sun Mar 23, 2025

Medicenna Therapeutics is now ranked among the top 10 undervalued stocks in the Biotechnology industry on the Toronto Stock Exchange or TSX Venture Exchange.

  • A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
  • Valuation methodology provided by Stockcalc (see below)

Biotechnology: Biotech and biopharmaceutical companies engaged in research, discovery, development, and production of innovative drug and drugrelated technologies.

Stocks in this category are held primarily for capital appreciation.

SymbolNameClose Price ($)Valuation ($)DifferenceAverage Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
MRVLMarvel Biosciences0.140.350.20 (138.8%)375166.50.00.0
CSCICosciens Biopharma4.8910.775.88 (120.2%)319515.20.00.0
WAVEWaverley Pharma0.010.020.01 (72.9%)32860.50.00.0
RVXResverlogix0.050.080.03 (55.5%)3509313.90.00.0
MBXMicrobix Biosystems0.410.620.21 (51.4%)17417855.60.029.3
XRTXXORTX Therapeutics1.492.180.69 (46.0%)101344.30.08.7
FRXFennec Pharmaceuticals9.5713.804.23 (44.2%)756261.20.00.0
IBOUniversal Ibogaine0.030.030.01 (38.4%)5.80.00.0
CYTOCytophage Technologies0.140.170.03 (24.8%)864717.50.00.0
MDNAMedicenna Therapeutics1.001.080.08 (8.3%)6180078.00.00.0

All data provided as of March 23, 2025.
The list is sorted by stocks with the greatest percentage difference between valuation and price.

Medicenna Therapeutics

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases.

Medicenna Therapeutics is listed under MDNA on the Toronto Stock Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.

Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:

  • Discounted Cash Flow (DCF)
  • Price & Other Comparables
  • Multiples
  • Adjusted Book Value (ABV)
  • Analyst Consensus

Artificial Intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.